Advance in studies on toxicity of aristolochic acid and analysis on risk factors / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 2246-2250, 2014.
Article
Dans Chinois
| WPRIM
| ID: wpr-330312
ABSTRACT
The renal toxicity and mutagenicity of aristolochic acid (AA) as well as its carcinogenicity on upper urinary tract transitional epithelial cells have been widely known. Since 2003, drug regulatory departments have successively cancelled the quality standards for AA-containing medicines such as Aristolochiae Radix, Aristolochiae Manshuriensis Caulis and Aristolchiae Fangchi Radix, and adopted measures for strengthening regulation and revising package insert or quality standards for other AA-containing medicines, including Aristolochia Cinnabarina Radix, Aristolochiae Fructus, Aristolochiae Mollissimae Herba, in order to control its safety risk. In recent years, domestic and foreign studies on AA have mainly involved action mechanism and clinical performance of AA toxicity, early-stage diagnosis and treatment method. In this paper, authors gave a brief summary and evaluation on risk factors for using AA-containing medicines, and offered measures and suggestions for preventing and controlling AA toxicity.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Médicaments issus de plantes chinoises
/
Chimie
/
Épidémiologie
/
Aristolochia
/
Acides aristolochiques
/
Utilisations thérapeutiques
/
Traitement médicamenteux
/
Effets secondaires indésirables des médicaments
/
Toxicité
Type d'étude:
Etude d'étiologie
/
Guide de pratique
Limites du sujet:
Animaux
/
Humains
langue:
Chinois
Texte intégral:
China Journal of Chinese Materia Medica
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS